These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11258617)

  • 21. Effects of aescin on cytochrome P450 enzymes in rats.
    Huang Y; Zheng SL; Zhu HY; Xu ZS; Xu RA
    J Ethnopharmacol; 2014; 151(1):583-90. PubMed ID: 24252494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytochrome P450 2B enzyme induction defect after 2,2',4,4',5,5'-hexachlorobiphenyl treatment in the fa/fa Zucker rat.
    Zannikos PN; Bandyopadhyay AM; Robertson LW; Blouin RA
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1565-70. PubMed ID: 8138968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic intragastric infusion of ethanol-containing diets induces CYP3A9 while decreasing CYP3A2 in male rats.
    Rowlands JC; Wang H; Hakkak R; Ronis MJ; Strobel HW; Badger TM
    J Pharmacol Exp Ther; 2000 Nov; 295(2):747-52. PubMed ID: 11046114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age- and sex-related alterations of microsomal drug- and testosterone-oxidizing cytochrome P450 in Sprague-Dawley strain-derived dwarf rats.
    Shimada M; Murayama N; Yamazoe Y; Hashimoto H; Ishikawa H; Kato R
    J Pharmacol Exp Ther; 1995 Nov; 275(2):972-7. PubMed ID: 7473190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of standardized Echinacea purpurea extract on rat cytochrome P450 expression level.
    Mrozikiewicz PM; Bogacz A; Karasiewicz M; Mikolajczak PL; Ozarowski M; Seremak-Mrozikiewicz A; Czerny B; Bobkiewicz-Kozlowska T; Grzeskowiak E
    Phytomedicine; 2010 Aug; 17(10):830-3. PubMed ID: 20374973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developmental changes in the constitutive and inducible expression of cytochrome P450 3A2.
    Wright MC; Edwards RJ; Pimenta M; Ribeiro V; Ratra GS; Lechner MC; Paine AJ
    Biochem Pharmacol; 1997 Oct; 54(7):841-6. PubMed ID: 9353139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of male-specific cytochrome P450s 2C11 and 3A2 in bile duct-ligated male rats: importance to reduced hepatic content of cytochrome P450 in cholestasis.
    Chen J; Murray M; Liddle C; Jiang XM; Farrell GC
    Hepatology; 1995 Aug; 22(2):580-7. PubMed ID: 7635428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of P450 3A by ethylbenzene without altering RNA levels.
    Yuan W; Cawley GF; Eyer CS; Backes WL
    Biochem Biophys Res Commun; 1994 Aug; 202(3):1259-65. PubMed ID: 8060301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Plasmodium berghei infection on cytochromes P-450 2E1 and 3A2.
    Uhl K; Grace JM; Kocisko DA; Jennings BT; Mitchell AL; Brewer TG
    Eur J Drug Metab Pharmacokinet; 1999; 24(2):169-76. PubMed ID: 10510746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex difference in induction of hepatic CYP2B and CYP3A subfamily enzymes by nicardipine and nifedipine in rats.
    Konno Y; Sekimoto M; Nemoto K; Degawa M
    Toxicol Appl Pharmacol; 2004 Apr; 196(1):20-8. PubMed ID: 15050404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Considerations for use of recombinant adenoviral vectors: dose effect on hepatic cytochromes P450.
    Callahan SM; Ming X; Lu SK; Brunner LJ; Croyle MA
    J Pharmacol Exp Ther; 2005 Feb; 312(2):492-501. PubMed ID: 15496614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malotilate, a hepatoprotectant, suppresses CYP2E1 expression in rats.
    Kim SG; Kwak JY; Lee JW; Novak RF; Park SS; Kim ND
    Biochem Biophys Res Commun; 1994 May; 200(3):1414-20. PubMed ID: 8185594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced inhibition of microsomal cytochrome P450 3A2 in rat liver during diltiazem biotransformation.
    Murray M; Butler AM
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1447-52. PubMed ID: 8968370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of the expression and inducibility of 12 rat cytochrome P450 isoforms by quantitative RT-PCR.
    Caron E; Rioux N; Nicolas O; Lebel-Talbot H; Hamelin BA
    J Biochem Mol Toxicol; 2005; 19(6):368-78. PubMed ID: 16421897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenobarbital induction of hepatic CYP2B1 and CYP2B2: pretranscriptional and post-transcriptional effects of gender, adult age, and phenobarbital dose.
    Agrawal AK; Shapiro BH
    Mol Pharmacol; 1996 Mar; 49(3):523-31. PubMed ID: 8643092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complex host cell responses to antisense suppression of ACHE gene expression.
    Galyam N; Grisaru D; Grifman M; Melamed-Book N; Eckstein F; Seidman S; Eldor A; Soreq H
    Antisense Nucleic Acid Drug Dev; 2001 Feb; 11(1):51-7. PubMed ID: 11258621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strain differences in cytochrome P450 mRNA and protein expression, and enzymatic activity among Sprague Dawley, Wistar, Brown Norway and Dark Agouti rats.
    Nishiyama Y; Nakayama SM; Watanabe KP; Kawai YK; Ohno M; Ikenaka Y; Ishizuka M
    J Vet Med Sci; 2016 May; 78(4):675-80. PubMed ID: 26806536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal delivery of antisense compounds.
    Brand RM; Iversen PL
    Adv Drug Deliv Rev; 2000 Oct; 44(1):51-7. PubMed ID: 11035197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iontophoretic delivery of a telomeric oligonucleotide.
    Brand RM; Iversen PL
    Pharm Res; 1996 Jun; 13(6):851-4. PubMed ID: 8792421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dermal/transdermal delivery of small interfering RNA and antisense oligonucleotides- advances and hurdles.
    Ita K
    Biomed Pharmacother; 2017 Mar; 87():311-320. PubMed ID: 28064104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.